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Background: Tetralogy of Fallot (TOF) is a cyanotic disease requiring early intervention. We assessed the
effect of right ventricular outﬂow tract (RVOT) stenting versus modiﬁed Blalock-Taussig shunt (mBTS) on
outcomes of surgical repair of TOF.
Methods: Fifteen palliated TOF infants underwent complete repair surgery. RVOT stenting was performed
in seven infants and mBTS was done in eight infants. Data on sequential patients who underwent surgery
were collected and reviewed retrospectively.
Results: Stenting group were signiﬁcantly younger (1.62  0.34 vs 2.80  0.52, p = 0.001), had lower body
weight(3.28  0.48vs5.03  0.67,p = 0.001)andlesserbodysurfacearea(0.20  0.01vs0.26  0.20,p = 0.001)
than the mBTS group at palliation. Mean right pulmonary artery (RPA) diameter in stenting group at palliation
was 2.9  0.54 mm (z-score -3.08  0.97) and increased at surgery to 4.6  0.49 mm (z-score –0.79  0.66)
(p = 0.001). The mean left pulmonary artery (LPA) diameter was 2.5  0.42 mm (z-score -3.3  0.86), which
increased to 3.3  0.40 mm (z-score -2.2  0.74) at surgery (p = 0.005). The mean RPA diameter in mBTS group
at palliation was 3.2  0.32 mm (z-score –2.9  0.70) and increased at surgery to 4.3  0.55 mm (z-score
–1.1  0.94) (p = 0.001). The mean LPA diameter was 2.8  0.26 mm (z-score -3.3  0.62), which increased to
3.2  0.24 mm (z-score –2.4  0.52) at surgery (p = 0.032). Repeat echocardiography showed signiﬁcant
increase in McGoon ratio and Nakata index in both groups (p = 0.001). No signiﬁcant differences were seen
between the two groups regarding surgical procedure and postoperative complications.
Conclusion: RVOT stenting is a safe and effective approach instead of mBTS in hazardous TOF infants with
hypercyanotic spell, small PAs and complex anatomies.
© 2018 Published by Elsevier B.V. on behalf of Cardiological Society of India. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Tetralogy of Fallot (TOF) is the most common cyanotic cardiac
anomalyandwasamongtheﬁrstcongenitalheartdiseases(CHD)tobe
both palliated and repaired successfully. Surgical repair or palliation is
oftenneededtorelievecyanosisduringthenewbornperiodbutcarries
an increased risk of mortality, particularly in high-risk infants of small
size and those having genetic disorders or other comorbidities [1–3].
Traditionally, the modiﬁed Blalock-Taussig shunt (mBTS) has
been the treatment of choice for improvement of pulmonary blood
ﬂow in infants with TOF, but is a challenging procedure in cyanotic* Corresponding author.
E-mail address: Sedighi1984@yahoo.com (M. Sedighi).
https://doi.org/10.1016/j.ihj.2018.06.020
0019-4832/© 2018 Published by Elsevier B.V. on behalf of Cardiological Society of
creativecommons.org/licenses/by-nc-nd/4.0/).
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an alternative for infants with hazardous symptoms which offers
advantages such as cyanosis stabilization, improvement of
pulmonary arteries (PAs) circulation and the option of elective
surgery in the future [5]. We undertook this research to describe
and compare our surgical experiences with TOF repair following
primary palliation by RVOT stenting and mBTS with particular
emphasis on the outcomes of subsequent surgery.
2. Materials and methods
2.1. Patient population
This retrospective study was carried out between May 2015 and
October 2016 on 18 infants with TOF, who were admitted at our India. This is an open access article under the CC BY-NC-ND license (http://
al Sciences from ClinicalKey.com by Elsevier on September 04, 2019.
ion. Copyright ©2019. Elsevier Inc. All rights reserved.
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by the local Ethics Committee and informed consent was obtained
from all individuals. Doppler and two-dimensional (2D) echocar-
diography and clinical evaluation were done routinely by the
pediatric cardiologist before and after catheterization and surgery.
Medical records, echocardiographic and surgical data were
reviewed retrospectively to compare variables between groups.
Measurements of the PAs diameter were made using echocardio-
graphic imaging and the z-scores were calculated based on the
body surface area (BSA)-adjusted z-scores using data published by
Detroit Children’s Hospital [6].
The cases for all infants were discussed at the multidisciplinary
cardiac meeting and the ﬁnal decision for palliation or single-stage
repair was taken according to the criteria outlined below. The
indicators for two-stage repair and primary palliation were active
cyanosis, low birth weight, (<5 kg) with or without spells and PAs
of small size (McGoon ratio <1.5; Nakata index 120 mm2/m2).
Accordingly, premature infants with severe RVOT stenosis and
hypercyanotic spells (SpO2  70) underwent RVOT stenting (n = 7)
and infants with PA stenosis and appropriate baseline saturation
were selected for mBTS (n = 8).
2.2. Procedural details
All cardiac catheterizations were performed under mild
anaesthesia with ﬂuoroscopic guidance. Catheterization was done
through the right femoral venous approach. The patients were
given 100 IU/kg of heparin in two doses (50 IU/kg ﬁrst and 50 IU/kg
half hour later) to maintain an activated clotting time of >200 s
after catheterization. Prophylactic intravenous antibiotic with
30 mg/kg of cefazolin was administrated at the beginning of the
procedure and in two subsequent doses every 8 h during the
following 24 h. A 4-F catheter was advanced through a sheath into
the right ventricle (RV) and a 0.14 guide wire was passed across the
RVOT into the main PA. After stabilization of the guide wire,
balloon angioplasty of the RVOT and the main PA was performed to
alleviate the difﬁculties of stent implementation into the RVOT
(Fig. 1). The stents were selected based on the size of the infants,
RVOT infundibular length and anticipated length of palliation.
Peripheral stents with nominal diameters that were 1–2 mm
greater than the annular dimension were selected and implanted
in the RVOT. The stents were 6–7 mm in diameter and 12–16 mm inFig. 1. Right ventricular injection in anteroposterior view from the same patient before 
stenosis and increased pulmonary artery ﬂow.
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removal and indicated a remarkable increase in pulmonary blood
ﬂow and oxygen saturation.
In the mBTS group, after induction of general anaesthesia,
expanded polytetraﬂuoroethylene grafts were placed from the
proximal brachial artery to the ipsilateral right or left PA through
the standard thoracotomy approach. The diameter of the shunts
was determined by the infant weight and size. The median shunt
diameter in the mBTS group was 3.5 mm (3.5 to 4.0 mm).
2.3. Statistical analysis
All statistical analyses were done using IBM SPSS ver. 22.0 (IBM;
USA). Continuous variables are presented as mean  standard
deviation. The two-tailed student t-test was used to identify
statistically signiﬁcant differences among these data points.
Categorical variables are presented as frequency (percentage)
and were analyzed using the Fisher’s exact test. All p-values of less
than 0.05 were considered to indicate statistical signiﬁcance.
3. Results
3.1. Demographic data
Table1 shows that the study population consisted of 8 (53.3%)
males and 7 (46.7%) females (p = 0.315). The cardiac comorbid-
ities were double-outlet right ventricle (DORV), PA stenosis,
atrioventricular septal defect (AVSD) and ventricular septal
defect (VSD). Infants who underwent single-stage repair and
infants with concomitant coronary anomalies (n = 3) were
excluded from the study. Patients in the RVOT stenting group
were signiﬁcantly younger (1.62  0.34 vs 2.80  0.52;
p = 0.001), had lower weights (3.28  0.48 vs 5.03  0.67;
p = 0.001) and BSA (0.20  0.01vs 0.26  0.20; p = 0.001) than
the mBTS group. Moreover, infants in the stenting group had
severe RVOT stenosis with hypercyanotic spells while infants in
mBTS group showed PA stenosis without spells and low
saturation. The mean oxygen saturation increased from 70%
to above 89% after palliation and was maintained above that.
Further postoperative echocardiography revealed two cases of
infundibular pulmonary stenosis (IPS) in the stenting group who
underwent subsequent catheterization and balloon dilatation.(A) and after (B) right ventricular outﬂow tract stenting shows signiﬁcant resolved
ences from ClinicalKey.com by Elsevier on September 04, 2019.
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Table 1
Demographic, clinical and paraclinical data of patients at palliation and surgery time.
Patient
No
Age
(month)
Gender Weight
(kg)
BSA
(m2)
Diagnosis Tet
spells
Hb1
(mg/dl)
O2 SAT1
(%)
Procedure Hb2
(mg/dl)
O2 SAT2
(%)
1 1.5 Female 2.5 0.22 TOF Yes 20.3 66 RVOT stent 16.2 91
2 2 Male 3.5 0.22 TOF/PS/VSD 0 0 18.4 65 0 0 14.5 86
3 1 Female 3.5 0.20 TOF 0 0 20.1 69 0 0 16.5 87
4 1.6 Female 2.5 19.0 TOF 0 0 20.9 70 0 0 17.0 94
5 1.8 Female 3.5 0.23 TOF 0 0 19.9 65 0 0 16.8 85
6 1.5 Female 3.9 0.19 TOF/DORV 0 0 18.5 64 0 0 14.5 89
7 2 Male 3.6 0.21 TOF 0 0 19.2 65 0 0 15.6 94
8 3 Male 5.1 0.26 TOF No 18.5 77 mBTS 14.9 90
9 3.5 Male 5.5 0.26 TOF/AVSD 0 0 17.7 72 0 0 14.0 87
10 3 Female 5.9 0.29 TOF 0 0 18.1 75 0 0 14.5 85
11 2 Female 4 0.25 TOF 0 0 17.9 68 0 0 15.0 90
12 3 Female 5.3 0.27 TOF/PS/VSD 0 0 18.8 79 0 0 15.9 93
13 3 Male 4.9 0.25 TOF/DORV 0 0 19.0 76 0 0 16.1 89
14 2 Male 4.1 0.23 TOF 0 0 19.1 77 0 0 15.7 92
15 2.9 Male 6 0.29 TOF 0 0 18.6 75 0 0 16.2 88
BSA: Body Surface Area, TOF: Tetralogy of Fallot, PS: pulmonary stenosis, VSD: ventricular septal defect, DORV: double outlet right ventricle, AVSD: atrio-ventricular septal
defect, RVOT: right ventricle outﬂow track, mBTS: modiﬁed Blalock Taussig shunt.
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The mean pulmonary valve dimension in stenting group was
3.7  0.7 (z-score: 7.01 1.7) versus 4.2  0.4 (z-score: 
7.0  1.0) in the mBTS group (p = 0.119). As Table 2 shows, the
mean diameter of the right pulmonary artery (RPA) in the stenting
group was 2.9  0.54 mm at palliation and increased to
4.6  0.49 mm at repair time (p = 0.001; z-score: 3.08  0.97 vs
0.79  0.66; p = 0.001).
Likewise, the mean diameter of the left pulmonary artery (LPA)
at palliation time was 2.5  0.42 mm increased to 3.3  0.40 mm
(p = 0.005) (z-score: 3.3  0.86 vs 2.2  0.74; p = 0.027). The
mean diameter of the RPA in the mBTS group was 3.2  0.32 mm at
palliation and increased to 4.3  0.55 mm at repair time (p = 0.001;
z-score: 2.9  0.70 vs –1.1  0.94; p = 0.002). The mean diameter
of the LPA was 2.8  0.26 mm at palliation and increased to
3.2  0.24 mm (p = 0.032; z-score: 3.3  0.62 vs 2.4  0.52;
p = 0.021). Moreover, the average McGoon ratio before palliation
was 0.82  0.04 in the stenting group versus 0.99  0.12 in the
mBTS group. The mean Nakata PA index in the stenting group was
90  6.4 mm2/m2 versus 112.7  6.1 mm2/m2 in the mBTS group.
At repair time, the McGoon ratio increased to 1.4  0.04 and
1.5  0.18 in the stenting and mBTS group, respectively (p = 0.001).
The Nakata PA index increased to 126.9  9.7 mm2/m2 in the
stenting group and 146  8.9 mm2/m2 in the mBTS groupTable 2
Comparison of pulmonary arteries variables at palliation and surgery time.
Variables Palliation
time
Range 
RVOT stent (n = 7)
RPA diameter
RPA Z-Score
2.9  0.54
3.08  0.97
2.1 - 3.5
4.6 to -2
LPA diameter
LPA Z-Score
McGoon ratio
Nakata index
2.5  0.42
3.3  0.86
0.82  0.04
90.0  6.4
1.9 - 3.1
4.7 to -2.2
0.79 - 0.92
83.1 – 98.6
mBTS (n = 8)
RPA diameter
RPA Z-Score
LPA diameter
3.2  0.32
2.9  0.70
2.8  0.26
2.9 – 3.8
3.8 to -2.05
2.5 – 3.1
LPA Z-Score
McGoon ratio
Nakata index
3.3  0.62
0.99  0.12
112.7  6.1
4.1 to -2.5
0.79 – 1.11
104 – 167
RVOT: right ventricle outﬂow track, RPA: right pulmonary artery, PLA: left pulmonar
Mean  Standard Deviation.
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remarkable increase after palliation in both groups, but was
slightly more desirable in the stented infants.
3.3. Surgical repair and complications
All infants underwent complete repair surgery six months
subsequent to palliation involving the establishment of a
cardiopulmonary bypass (CPB) and midline sternotomy. In the
stenting group, stent removal was done completely in four infants.
One infant with a diminutive PA in the mBTS group received RV-PA
conduit because of undeveloped PA after the mBTS. In another
case, a small portion of the stent was preserved in place to avoid
damage to the surrounding cardiac tissue. In the mBTS group,
shunt closure was done successfully in all infants. Three infants
had mBTS on the right side and four on the left side. One infant
underwent bilateral mBTS. One infant experienced stenosis at the
site of shunt anastamosis that was relieved at the time of repair.
Four infants in stenting group and ﬁve infants in mBTS group
(57.1% vs 62.5%) received a transannular patch (TAP). In two cases
in the stenting group, the stents were placed in the PA valve
pathway. There were no signiﬁcant differences between groups
regarding the TAP rate, aortic cross-clamp (ACC) and CPB time,
intubation and ICU stay. However, the operation time was slightly
more prolonged in the shunt group due to cardiac tissue adhesion.Surgery
time
Range p value
4.6  0.49
0.79  0.66
4–5.2
1.6 to 0.0
0.001
0.001
3.3  0.40
2.2  0.74
1.45  0.04
126.9  9.7
2.8–3.8
3.3 to -1.3
1.40 – 1.53
112 – 145.6
0.005
0.027
0.001
0.001
4.3  0.55
1.1  0.94
3.2  0.24
4 – 5
1.6 to -0.25
2.8 – 3.5
0.001
0.002
0.032
2.4  0.52
1.5  0.18
146.1  8.9
3.2 to -1.8
1.4 – 1.96
140 - 167
0.021
0.001
0.001
y artery. mBTS: modiﬁed Blalock Taussig shunt. Continues data are presented as
Sciences from ClinicalKey.com by Elsevier on September 04, 2019.
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Fig. 2. Pulmonary arteries growth based on Z-Score index at the time of palliation
and surgery, *P < 0.05.
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prematurity and acute respiratory distress syndrome (ARDS) after
palliation. One infant in mBTS group died from endocarditis and
sepsis ﬁve days after surgery (Table 3). No complications, such as
shunt failure or occlusion, stent fracture, postoperative tachycar-
dia, complete heart block, bleeding or RV failure, were observed.
4. Discussion
TOF is the common form of cyanotic CHD and represents about
6% of congenital morbidities. The presence and degree of cyanosis
in this condition depend on the degree of RVOT obstruction and
PAs development. There are various types of anatomical features in
TOF that have different clinical and hemodynamic outcomes. For
many years, staged surgical repair of the TOF has been a standard
approach, especially in high-risk infants with low ages and weights
and complex anatomies. Accordingly, infants with TOF who have
complications such as critical RVOT obstruction, PA hypoplasia and
the presence of major aortopulmonary collateral artery
(MAPCA) are candidates for primary palliation as a ﬁrst step to
avert hypoxia, improvement of oxygen saturation and PAs
development until the complete repair [2,7–9].
After the introduction of mBTS, this surgical approach has been
performed extensively and has rescued the lives of numerous
infants with TOF. However, mBTS palliation is associated with
serious problems, particularly shunt thrombosis and decreased
pulmonary blood ﬂow that increases the chance of sudden death
and morbidity. The young age, low weight, small PAs diameter and
complex cardiac anatomy of the infants are major risk factors for
shunt failure.Table 3
Clinical data of patients at surgery time.
Variable a,b RVOT stenting
(n = 7)
mBTS
(n = 8)
p value
ACC time (min) a 111.8  27.5 89.3  20.3 0.093
CPB time (min)
TAP b
IPS
Mortality
165.5  49.4
4 (57.1%)
2(28.6%)
1(14.3%)
129.2  38.5
5 (62.5%)
0
1(12.5%)
0.134
0.622
0.200
0.733
ICU stay (hour) 94.4  4.2 94.3  3.9 0.980
ACC: aortic cross-clamp. CPB: cardiopulmonary bypass, TAP: transannular patch,
IPS: infundibular pulmonary stenosis, ICU: intensive care unit.
a Continues data are presented as Mean  Standard Deviation.
b Categorical data are presented as Frequency (Percentage).
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relatively rare life-threatening condition [10,11].In our series,
the majority of infants who underwent mBTS had favorable PAs
growth and showed no sign of shunt failure and occlusion before
complete repair. On the other hand, there is no possibility for
shunting in infants with underdeveloped PAs who experience
hypercyanotic spells during the neonatal period. RVOT stenting
was introduced as a substitute for primary palliative or corrective
surgery in high-risk infants. RVOT stenting increases the PAs
blood ﬂow, improves systemic saturation and ameliorates
hemodynamic conditions. More importantly, RVOT stenting
enables symmetric growth of both PA branches, which may be
asymmetric in mBTS [7,12–16],
Our ﬁndings are consistent with those of others studies that
report remarkable growth of both PAs after either palliative
approach (p < 0.05), which was valuable in high-risk cases,
especially those with tet spells [3,5,8,17]. Despite the advantages
of RVOT stenting over mBTS, early palliation in symptomatic
infants increases the chance of requiring TAP at repair time. More
importantly, infants with RVOT stents may be at risk for RV-PA
conduits, which is a major limitation of stenting and will likely
require future surgery. In our series, similar to other investigations,
there were no signiﬁcant differences between RVOT stenting and
mBTS regarding TAP requirement, ACC time, CPB time and
postoperative complications [5,18]. The present study had some
limitations. Firstly, this retrospective study included a small
number of infants who underwent complete surgical repair of TOF
following primary palliation. Hence, the statistical analyses may
not have sufﬁcient power to support a deﬁnitive conclusion in
favor of palliation. Secondly, as in previous studies, a longer follow-
up time is needed to assess PAs growth and RVOT function.
5. Conclusion
Our outcomes support the assertion that RVOT stenting is a safe
and valuable approach for use in place of mBTS in infants who
exhibit hazardous TOF symptoms with hypercyanotic spells,
underdeveloped PAs and complex anatomies. Moreover, RVOT
stenting improved oxygen saturation, increased the z-score of both
PAs and noticeably decreased the spells until surgical repair was
possible. There is no doubt that single-stage repair can successfully
be done in stable and non-cyanotic TOF cases, but RVOT stenting as
a primary palliation is a safe and effective procedure for high-risk
TOF cases to avert the risks of mBTS.
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